Thank you and good afternoon, everyone. As many of you know, I am the Co-Founder of Caritage, a London-based investment firm focused on digital assets and emerging technologies. Over the past several ...

If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or refractory BRAF-altered pediatric low-grade glioma, ...

Fasting is a cultural and religious practice with a long history in humanity. Whether one is spiritually inclined or not, ...